Summary
Based on clinical experience, infants with congestive heart failure are given larger doses of digoxin than adults, whether calculated on the basis of body weight or surface area. The reasons for this difference in dosage are not clear. The myocardium of the infants might be more resistant to the effects of digoxin than that of adults, and/or differences might exist between infants and adults concerning the absorption, distribution and elimination of the glycoside.
Infants have been found to absorb digoxin in solution at the same rate and to the same extent as adults. The relative distribution of the glycoside to different tissues is also similar in the two age-groups. However, the binding of digoxin to several tissues seems to be more extensive in infants than in adults. In agreement with this, the apparent volume of distribution of the glycoside is larger in infants than in adults. In infants (except neonates), the elimination half-life of digoxin is shorter than in adults. As no enhanced urinary excretion has been found in infants there might be a non-renal elimination of the glycoside.
With most prevailing dose schedules for digoxin, serum concentrations higher than those considered optimum for adults are often obtained in infants. It is known that infants tolerate higher serum digoxin concentrations than adults without developing signs of toxicity. However, it is not known whether such high concentrations are necessary for obtaining an adequate inotropic effect on the myocardium of the infants. If the relation between serum concentration and effect is the same in infants and adults, the loading (digitalising) dose generally given to infants is unnecessarily high.
Similar content being viewed by others
References
Allonen, H.; Kanto, J. and Iisalo, E.: The foetomaternal distribution of digoxin in early human pregnancy. Acta Pharmacologica et Toxicologica 39: 477–480 (1976).
Andersson, K.-E.; Bertler, A. and Wettrell, G.: Post-mortem distribution and tissue concentrations of digoxin in infants and adults. Acta Paediatrica Scandinavica 64: 497–504 (1975).
Bloom, P.M.; Nelp. W.B. and Tuell, S.H.: Relationship of the excretion of tritiated digoxin to renal function. American Journal of Medical Sciences 251: 133–144 (1966).
Butler, V.P.: Assays of digitalis in the blood. Progress in Cardiovascular Diseases 5: 571–600 (1972).
Caldwell, J.H. and Cline, C.T.: Biliary excretion of digoxin in man. Clinical Pharmacology and Therapeutics 19: 410–415 (1976).
Coltart, D.J.; Howard, M.R. and Chamberlain, D.: Myocardial and skeletal muscle concentrations of digoxin in patients on long term therapy. British Medical Journal 2: 318–319 (1972).
Coltart, J.D.; Gullner, H.-G.; Billingham, M.; Goldman, R.H.; Stinson, E.B.; Kaiman, S.M. and Harrison, D.C.: Physiological distribution of digoxin in human heart. British Medical Journal 2: 733–736 (1974).
Cree, J.E.; Coltart, D.J. and Howard, M.R.: Plasma digoxin concentration in children with heart failure. British Medical Journal 1: 443–444 (1973).
Deutscher, R.N.; Harrison, D.C. and Goldman, R.H.: The relation between myocardial 3H-digoxin concentration and its hemodynamic effects. American Journal of Cardiology 29: 47–55 (1972).
Doherty, J.E.: The clinical pharmacology of digitalis glycosides: A review. American Journal of Medical Sciences 255: 383–414 (1968).
Duhme, D.W.; Greenblatt, D.J. and Koch-Weser, J.: Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program. Annals of Internal Medicine 80: 516–519 (1974).
Dungan, W.T.; Doherty, J.E.; Harvey, C.; Char, F. and Dalrymple, G.V.: Tritiated digoxin XVIII. Studies in infants and children. Circulation 46: 983–988 (1972).
Dohlemann, Ch. and Buhlmeyer, K.: Ergebnisse vergleichender oraler und intravenoser Digitalis-Therapie bei Sauglingen. Monatschrift fur Kinderheilkunde 120: 458–461 (1972).
Ehrnebo, M.; Agurell, S.; Jailing, B. and Boreus, L.O.: Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adults. European Journal of Clinical Pharmacology 3: 189–193 (1971).
Evans, E.F.; Proctor, J.D.; Fratkin, M.J.; Velandia, J. and Wasserman, A.J.: Blood flow in muscle groups and drug absorption. Clin. Pharmacol. Ther. 17: 44–47 (1975).
Friis-Hansen, B.: Body composition during growth. In vivo measurements and biochemical data correlated to differential anatomical growth. Pediatrics 47: 264–274 (1971).
Gladtke, E. and Heimann, G.: The rate of development of elimination functions in kidney and liver of young infants; in Morselli, Garattini and Sereni (Eds) Basic and Therapeutic Aspects of Perinatal Pharmacology, pp.393–403 (Raven Press, New York 1975).
Glynn, I.M.: The action of cardiac glycoside on ion movements. Pharmacological Reviews 16: 381–407 (1964).
Gorodischer, R.; Jusko, W.J. and Yaffe, S.J.: Tissue and erythrocyte distribution of digoxin in infants. Clinical Pharmacology and Therapeutics 19: 256–263 (1976a).
Gorodischer, R.; Jusko, W.J. and Yaffe, S.J.: Renal clearance of digoxin in young infants. In preparation (1976b).
Gorodischer, R.; Krasner, J. and Yaffe, S.J.: Serum protein binding of digoxin in newborn infants. Research Communications in Pathology and Pharmacology 9: 387–390 (1974).
Greenblatt, D.J.; Duhme, D.W.; Koch-Weser, J. and Smith, T.W.: Evaluation of digoxin bioavailability in single-dose studies. New Engl. J. Med. 289: 651–654 (1973).
Greenblatt, D.J.; Duhme, D.W.; Koch-Weser, J. and Smith, T.W.: Bioavailability of digoxin tablets and elixir in the fasting and postprandial states. Clinical Pharmacology and Therapeutics 16: 444–448 (1974).
Greenblatt, D.J. and Koch-Weser, J.: Clinical pharmacokinetics (First of two parts). New England Journal of Medicine 293: 702–705 (1975).
Greenblatt, D.J.; Smith, T.W. and Koch-Weser.: Bioavailability of drugs: The digoxin dilemma. Clinical Pharmacokinetics 1: 36–51 (1976).
Greenblatt, D.J. and Koch-Weser, J.: Intramuscular injection of drugs. New Engl. J. Med. 295: 542–546 (1976).
Hall, W.H. and Doherty, J.E.: Tritiated digoxin XXII. Absorption and excretion in malabsorption syndromes. American Journal of Medicine 56: 437–442 (1974).
Hayes, C.J.; Butler, V.P. and Gersont, W.M.: Serum digoxin studies in infants and children. Pediatrics 52: 561–568 (1973).
Heizer, W.D.; Smith, T.W. and Goldfinger, S.W.: Absorption of digoxin in patients with malabsorption syndromes. New England Journal of Medicine 285: 257–259 (1971).
Hernandez, A.; Burton, R.M.; Pagtakhan, R.D. and Goldring, D.: Pharmacodynamics of 3H-digoxin in infants. Pediatrics 44: 418–428 (1969).
Hartel, G.; Kyllonen, K.; Merikallio, E.; Ojala, K.; Manninen, V. and Reissell, P.: Human serum and myocardium digoxin. Clinical Pharmacology and Therapeutics 19: 153–157 (1976).
Iisalo, E. and Dahl, M.: Serum levels and renal excretion of digoxin during maintenance therapy in children. Acta Paediatrica Scandinavica 63: 699–704 (1974).
Iisalo, E. and Ruikka, I.: Serum levels and renal excretion of digoxin in elderly. A comparison between three different preparations. Acta Medica Scandinavica 196: 59–63 (1974).
Johnson, B.F. and Bye, C.: Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration. British Heart Journal 37: 203–208 (1975).
Jusko, W.J.: Pharmacokinetic principles in pediatric pharmacology. Pediatric Clinics of North America 19: 81–100 (1972).
Jusko, W.J.; Conti, D.R.; Molson, A.; Kuritsky, P.; Giller, J. and Schultz, R.: Digoxin absorption from tablets and elixir; the effect of radiation-induced malabsorption. Journal of the American Medical Association 230: 1554–1555 (1974a).
Jusko, W.J.; Szefler, S.J. and Goldfarb, A.L.: Pharmacokinetic design of digoxin dosage regimens in relation to renal function. Journal of Clinical Pharmacology 14: 525–535 (1974b).
Karjalainen, J.; Ojala, K. and Reissell, P.: Tissue concentrations of digoxin in an autopsy material. Acta Pharmacologica et Toxicologica 34: 385–390 (1974).
Kim, P.W.; Krasula, R.W.; Soyka, L.F. and Hastreiter, A.R.: Post-mortem tissue digoxin concentrations in infants and children. Circulation 52: 1128–1131 (1975).
Koch-Weser, J.: The serum level approach to individualization of drug dosage. European Journal of Clinical Pharmacology 9: 1–8 (1975).
Koup, J.R.; Greenblatt, D.J.; Jusko, W.J.; Smith, T.W. and Koch-Weser, J.: Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses. Journal of Pharmacokinetics and Biopharmacy 3: 181–192 (1975).
Krasula, R.W.; Pellegrino, P.A.; Hastreiter, A.R. and Soyka, L.F.: Serum levels of digoxin in infants and children. Journal of Pediatrics 81: 566–569 (1972).
Krasula, R.W.; Hastreiter, A.R.; Levitsky, S.; Yanagi, R. and Soyka, L.F.: Serum, atrial and urinary digoxin levels during cardiopulmonary bypass in children. Circulation 49: 1047–1052 (1974a).
Krasula, R.W.; Yanagi, R.; Hastreiter, A.R.; Levitsky, S. and Soyka, K.F.: Digoxin intoxication in infants and children: Correlation with serum levels. Journal of Pediatrics 84: 265–269 (1974b).
Larese, R.J. and Mirkin, B.L.: Kinetics of digoxin absorption and relation of serum levels to cardiac arrhythmias in children. Clinical Pharmacology and Therapeutics 15: 387–396 (1974).
Levine, O.R. and Blumenthal, S.: Digoxin dosage in premature infants. Pedatrics 29: 18–25 (1962).
Levy, A.M.; Leamon, D.M. and Hanson, J.S.: Effects of digoxin on systolic time intervals of neonates and infants. Circulation 46: 816–823 (1972).
Lindenbaum, J.; Mellow, M.H.; Blackstone, M.O. and Butler, V.P.: Variation in biologic availability of digoxin from four preparations. New England Journal of Medicine 285: 1344–1347 (1971).
Manninen, V.; Melin, J.; Apajalahti, A. and Karesoja, M.: Altered absorption of digoxin in patients given propantheline and metoclopramide. Lancet 1: 398–400 (1973).
Marini, A.; Sereni, F. and Bottino, D.: Digoxin dosage in newborn animals and infants. Pediatrics 30: 332–333 (1962).
Miller, W.W. and Gilliland, K.: Developmental differences in canine myocardial adenosine triphosphatase activity. Circulation 46 (Suppl. II) abstract No. 140 (1972).
Morselli, P.L.: Clinical pharmacokinetics in neonates. Clinical Pharmacokinetics 1: 81–98 (1976).
Morselli, P.L.; Assael, B.M.; Gomeni, R.; Mandelli, M.; Marini, A.; Reali, E.; Visconti, U. and Sereni, F.: Digoxin pharmacokinetics during human development; in Morselli, Garattini and Sereni (Eds) Basic and Therapeutic Aspects of Perinatal Pharmacology, pp. 377–392 (Raven Press, New York 1975).
Moss, A.J.; Finkelstein, S.; Crudrup, C.; Young, G.A.; Dooley, R.R. and Osker, A.B.: Absorption of digoxin in children with cystic fibrosis. Journal of Pediatrics 86: 295–297 (1975).
Neill, C.A.: The use of digitalis in infants and children. Progress in Cardiovascular Diseases 7: 399–416 (1965).
Nyberg, L.; Andersson, K.-E. and Bertler, A.: Bioavailability of digoxin from tablets II. Radioimmunoassay and disposition pharmacokinetics of digoxin after intravenous administration. Acta Pharmaceutica Suecia 11: 459–470 (1974).
Ogilvie, R.J. and Ruedy, J.: An educational program in digitalis therapy. Journal of American Medical Association 222: 50–55 (1972).
Oliver, G.G.; Taxman, R. and Frederickson, R.: Influence of congestive heart failure on digoxin blood levels; in Storstein, Nitter-Hauge and Storstein (Eds) Symposium on Digitalis, Oslo, Norway, p. 336 (Gyldendal Norsk Forlag, Oslo 1973).
O’Malley, E.N.; Coleman, W.B. and Stevenson, I.H.: Plasma digoxin levels in infants. Archives of Diseases of Childhood 48: 55–57 (1973).
Pinsky, W.W.; Jacobsen, J.R.; Gillette, P.C.; Burdine, J.A.; Adams, J.M.; Rudolf, R.J. and McNamara, D.G.: Serum digoxin levels in premature infants. Pediatric Research 10: 333 (1976).
Reuning, R.H.; Sams, R.A. and Notari, R.E.: Role of pharmacokinetics in drug dosage adjustment I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin. Journal of Clinical Pharmacology 13: 127–141 (1973).
Riegelman, S.; Loo, J.C.K. and Rowland, M.: Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. Journal of Pharmaceutical Sciences 57: 117–123 (1968).
Riggs, D.S.: The mathematical approach to physiological problems, pp. 193–220 (Williams and Wilkins, Baltimore 1963).
Rogers, M.C.; Willerson, J.T.; Goldblart, A. and Smith, T.W.: Serum digoxin concentrations in the human fetus, neonate and infant. New England Journal of Medicine 287: 1010–1013 (1972).
Rowland, M.; Benet, L.Z. and Graham, G.C.: Clearance concepts in pharmacokinetics. Journal of Pharmacokinetics and Biopharmacy 1: 123–133 (1973).
Sapin, O.S.; Donoso, E. and Blumenthal, S.: Digoxin dosage in infants. Pediatrics 18: 730–738 (1956).
Schwarz, A.: Is the cell membrane Na+ —K+-ATPase enzyme system the pharmacological receptor for digitalis? Circulation Research 39: 2–7 (1976).
Smith, T.W.; Butler, V.P. and Haber, E.: Determination of therapeutic and toxic serum digoxin concentrations by radioimmunassay. New England Journal of Medicine 281: 1212–1216 (1969).
Soyka, L.F.: Digoxin: Placental transfer, effects on the fetus, and therapeutic use in the newborn. Clinics in Perinatology 2: 23–35 (1975).
Steiness, E.; Svensen, O. and Rasmussen, F.: Plasma digoxin after parenteral administration. Local reaction after intramuscular injection. Clinical Pharmacology and Therapeutics 16: 430–434 (1974).
Steiness, E.: Renal tubular secretion of digoxin. Circulation 50: 103–107 (1974).
Teorell, T.: Kinetics of distribution of substances administered to the body. Archives Internationales de Pharmacodynamic et de Therapie 57: 205–240 (1937).
Vargo, T.; Lewis, R.; Burdine, J. and Schwartz, A.: Comparison between puppies and adult dogs following infusion of digoxin. Pediatric Research 8: 355 (1974).
Weintraub, M. and Lasagna, L.: Serum and tissue concentrations of digoxin: A clinical and pathologic analysis (abstract). Clinical Pharmacology and Therapeutics 14: 149 (1973).
Wettrell, G.; Andersson, K.-E.; Bertler, A. and Lundstrom, N.R.: Concentrations of digoxin in plasma and urine in neonates, infants and children with heart disease. Acta Paediatrica Scandinavica 63: 705–710 (1974).
Wettrell, G. and Adersson, K.-E.: Absorption of digoxin in infants. European Journal of Clinical Pharmacology 9: 49–55 (1975).
Wettrell, G.: Digoxin therapy in infants. A clinical pharmacokinetic study. Acta Paediatrica Scandinavica Suppl. 257 (1976a).
Wettrell, G.: Distribution and elimination of digoxin in infants. European Journal of Clinical Pharmacology. In press (1976b).
Wettrell, G.; Andersson, K.-E. and Nyberg, L.: Effects of exchange transfusions on the elimination of digoxin in neonates. European Journal of Clinical Pharmacology 10: 25–29 (1976).
Windorfer, jr. A.; Pringsheim, W.; Gadeke, R. and Schumacher, G.: Digoxin-Serumkonzentrationen und Digitalisuberdosierung bei Neugeborenen, Sauglingen und Kleinkindern. Zeitschrift fur Kinderheilkunde 118: 207 (1974).
Windorfer, A. and Karitsky, D.: Uber die Bedutung der Albumin-Bilirubin-Bindung bei der medikamentosen Therapie in Neugeborenalter. Monatschrift fur Kinderheilkunde 123: 27–30 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wettrell, G., Andersson, KE. Clinical Pharmacokinetics of Digoxin in Infants. Clin Pharmacokinet 2, 17–31 (1977). https://doi.org/10.2165/00003088-197702010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-197702010-00002